Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy

Circulation Research

Volumn 100, Issue 6, 2007, Pages 766-768

  Osio, Adriana ^a   Tan, Lily ^a   Chen, Suet N ^a   Lombardi, Raffaella ^a   Nagueh, Sherif F ^b   Shete, Sanjay ^c   Roberts, Robert ^d   Willerson, James T ^a   Marian, Ali J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYOZENIN 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HAPLOTYPE; HEART ARRHYTHMIA; HEART HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRON; MALE; MARKER GENE; MISSENSE MUTATION; MUTATION RATE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SHORT TANDEM REPEAT; SYMPTOM;

AFRICAN CONTINENTAL ANCESTRY GROUP; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CHILD; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; GENE FREQUENCY; GENES, DOMINANT; HAPLOTYPES; HUMANS; LOD SCORE; MALE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION, MISSENSE; PEDIGREE; PENETRANCE; PHENOTYPE; SEQUENCE HOMOLOGY, AMINO ACID; TWINS, DIZYGOTIC;

EID: 34147182155     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000263008.66799.aa     Document Type: Article

References (8)

1. Marian AJ. Clinical and molecular genetic aspects of hypertrophic cardiomyopathy. Current Cardiol Rev. 2005;1:53-63.
2. Morita H, Seidman J, Seidman CE. Genetic causes of human heart failure. J Clin Invest. 2005;115:518-526.
3. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227-2232.
4. Frey N, Richardson JA, Olson EN. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci U S A. 2000;97:14632-14637.
5. Frey N, Barrientos T, Shelton JM, Frank D, Rutten H, Gehring D, Kuhn C, Lutz M, Rothermel B, Bassel-Duby R, Richardson JA, Katus HA, Hill JA, Olson EN. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med. 2004;10:1336-1343.
6. Knoll R, Hoshijima M, Hoffman HM, Person V, Lorenzen-Schmidt I, Bang ML, Hayashi T, Shiga N, Yasukawa H, Schaper W, McKenna W, Yokoyama M, Schork NJ, Omens JH, McCulloch AD, Kimura A, Gregorio CC, Poller W, Schaper J, Schultheiss HP, Chien KR. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 2002;111:943-955.
7. Fatkin D, McConnell BK, Mudd JO, Semsarian C, Moskowitz IG, Schoen FJ, Giewat M, Seidman CE, Seidman JG. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest. 2000;106:1351-1359.
8. Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG, Thompson JD. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003;31:3497-3500.